Dr. Kim's research focuses on the role that epigenetic regulation plays in pluripotency and cancer. 

Kitai Kim is the Director of the Human Stem Cell and Genome Engineering Center at UCLA. He earned his PhD in Virology/Oncology from the University of Wisconsin-Madison and completed postdoctoral training in the Hematology/Oncology Department at Boston Children’s Hospital, affiliated with Harvard Medical School. He previously served as a faculty member at Memorial Sloan Kettering Cancer Center (MSKCC), affiliated with Weill Medical College of Cornell University, before relocating his lab to UCLA in 2021.